Ionis’ pioneering antisense technology to be featured in multiple presentations at American Heart Association (AHA) Scientific Sessions 2020
- Thursday, November 12, 2020, 7:12
- PR Newswire
- Add a comment
CARLSBAD, Calif., Nov. 12, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today the upcoming presentations of clinical and non-clinical data for several of its investigational antisense medicines for cardiovascular disease at the American Heart Association…
About the Author
admin has written 20826 stories on this site.